Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Assets: 2021-2022

Historic Return on Assets for Atea Pharmaceuticals (AVIR) over the last 2 years, with Sep 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Assets rose 2.00% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year increase of 2.00%. This contributed to the annual value of 0.15% for FY2021, which is N/A change from last year.
  • Atea Pharmaceuticals' Return on Assets amounted to 0.05% in Q3 2022, which was up 134.73% from 0.02% recorded in Q2 2022.
  • In the past 5 years, Atea Pharmaceuticals' Return on Assets registered a high of 0.15% during Q4 2021, and its lowest value of 0.02% during Q2 2022.
  • Over the past 2 years, Atea Pharmaceuticals' median Return on Assets value was 0.04% (recorded in 2021), while the average stood at 0.06%.
  • Examining YoY changes over the last 5 years, Atea Pharmaceuticals' Return on Assets showed a top increase of 3bps in 2022 and a maximum decrease of 2bps in 2022.
  • Quarterly analysis of 2 years shows Atea Pharmaceuticals' Return on Assets stood at 0.15% in 2021, then rose by 2bps to 0.05% in 2022.
  • Its Return on Assets was 0.05% in Q3 2022, compared to 0.02% in Q2 2022 and 0.06% in Q1 2022.